New 3-Antigen HBV Vaccine With Pre-S1 and Pre-S2 for Adults Induces a High Immune Response and Long Term Persistence of Anti-HBs Antibodies in Adults April 18, 2023 | New 3-Antigen HBV Vaccine With Pre-S1 and Pre-S2 for Adults Induces a High Immune Response and Long Term Persistence of Anti-HBs Antibodies in Adults Conference: 33rd European Congress of Clinical Microbiology and Infectious Diseases (EECMID) Date: April 18, 2023